Injection Procedures
BOTOX®
- BOTOX® Cosmetic is a natural, purified protein that relaxes wrinkle-causing muscles, creating a smoothed and improved appearance.
- BOTOX® Cosmetic is administered via a few tiny injections of purified protein into the muscle to block nerve impulses that trigger wrinkle-causing muscle contractions.
- BOTOX® Cosmetic is a simple and quick, minimally invasive treatment that delivers dramatic results with no downtime.
- Maximum effect of BOTOX® Cosmetic should occur at 30 days;
however, a majority of patients show response by day 7. - Results of BOTOX® Cosmetic treatment may persist for up to 4 months,
after which re-treatment is recommended.
Juviderm™
- An injectable, smooth gel dermal filler
- For the correction of moderate to severe facial folds and wrinkles
- Nonanimal-sourced hyaluronic
- Not collagen
- JUVÉDERM™ injectable gel is a hyaluronic acid (HA)
- Naturally occurring in the body
- Not animal-sourced acid (HA)
- Injected into facial folds and wrinkles
- Fills the area just below the surface
- Cross-linking of HA extends duration
- Cross-linking is chemical processing of HA to bind strands of polymers to each other
- More cross-linking means more resistance to enzymatic degradation1
- Uncross-linked HA is absorbed into the body within 7 days
Latisse
Question: How is LATISSE® solution different from other products?
Answer: Only LATISSE® (bimatoprost ophthalmic solution) 0.03% has been approved by the FDA as a product indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness.
Question: How soon will patients see results?
Answer: The onset of effect with LATISSE® (bimatoprost ophthalmic solution) 0.03% is gradual. In the clinical trials, the majority of patients saw significant improvement by 2 months.
Question: What are the side effects with LATISSE® (bimatoprost ophthalmic solution) 0.03%?
Answer: The most frequently reported adverse events were eye itching, redness in the eyes, skin hyperpigmentation, eye irritation, dry eye symptoms, and redness of the eyelid. These events occurred in less than 4% of patients.¹ If patients develop a new eye condition (like an eye trauma or infection), experience a sudden decrease in vision, have eye surgery, or develop any eye reactions, particularly an infection and eyelid reactions, the healthcare professional may determine whether or not to continue the patient’s use of LATISSE®.
|
